Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


08.07.2019

1 Acta Neurol Scand
2 AJNR Am J Neuroradiol
2 Ann Neurol
1 Clin Ther
1 Curr Treat Options Neurol
1 J Neurol
1 J Neurol Sci
1 Neurologia


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. LAAKSO SM, Viitala M, Kuusisto H, Sarasoja T, et al
    Multiple sclerosis in Finland 2018- data from the national register.
    Acta Neurol Scand. 2019 Jul 4. doi: 10.1111/ane.13145.
    PubMed     Text format     Abstract available


    AJNR Am J Neuroradiol

  2. FORSLIN Y, Martola J, Bergendal A, Fredrikson S, et al
    Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2019 Jun 27. pii: ajnr.A6112. doi: 10.3174/ajnr.A6112.
    PubMed     Text format     Abstract available

  3. LECLER A, El Sanharawi I, El Methni J, Gout O, et al
    Improving Detection of Multiple Sclerosis Lesions in the Posterior Fossa Using an Optimized 3D-FLAIR Sequence at 3T.
    AJNR Am J Neuroradiol. 2019 Jun 27. pii: ajnr.A6107. doi: 10.3174/ajnr.A6107.
    PubMed     Text format     Abstract available


    Ann Neurol

  4. CREE BAC, Hauser SL
    Reply to "Silent progression or bout-onset progressive multiple sclerosis?"
    Ann Neurol. 2019 Jun 28. doi: 10.1002/ana.25536.
    PubMed     Text format    

  5. GIL-PEROTIN S, Alcala C, Perez-Miralles FC, Casanova B, et al
    Silent progression or bout-onset progressive multiple sclerosis?
    Ann Neurol. 2019 Jun 28. doi: 10.1002/ana.25537.
    PubMed     Text format    


    Clin Ther

  6. KRESA-REAHL K, Repovic P, Robertson D, Okwuokenye M, et al
    Corrigendum to "Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-Reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study" [Clinical Therape
    Clin Ther. 2019 Jun 26. pii: S0149-2918(19)30297.
    PubMed     Text format    


    Curr Treat Options Neurol

  7. WOOLISCROFT L, Silbermann E, Cameron M, Bourdette D, et al
    Approaches to Remyelination Therapies in Multiple Sclerosis.
    Curr Treat Options Neurol. 2019;21:34.
    PubMed     Text format     Abstract available


    J Neurol

  8. BERENGUER-RUIZ L, Gimenez-Martinez J, Palazon-Bru A, Sempere AP, et al
    Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.
    J Neurol. 2019 Jun 29. pii: 10.1007/s00415-019-09450.
    PubMed     Text format     Abstract available


    J Neurol Sci

  9. MUCCILLI A, Nehme A, Labrie M, Girard M, et al
    Varicella-zoster virus vasculopathy in a multiple sclerosis patient on fingolimod.
    J Neurol Sci. 2019;403:119-121.
    PubMed     Text format    


    Neurologia

  10. CIFUENTES-CANOREA P, Nieves-Moreno M, Saenz-Frances F, Santos-Bueso E, et al
    Early and recurrent macular oedema in a patient treated with fingolimod.
    Neurologia. 2019;34:206-207.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: